THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
![]()
We combine innovative ingredients synergistically to support the connective tissue matrix, and this, in part, has been the key to our success in achieving exceptional growth
Share this Article:
Tweet
|
Company
Hymed
Headquarters
Bethlehem, PA
Management
Anita Petito, Vice President
Description
The company is a developer of innovative products that use collagen(the chief structural protein of the body), hyaluronic acid and glycosaminoglycan chemistry for the human and animal care with applications in wound care, joint/tissue support, surgery, eye care, dental, and dermatology. Hymed formulated a specialized hydrolyzed collagen—hyCURE—fragmented collagen, which is a core ingredient in many of its products that focus on cell/tissue applications. Hydrolyzed collagen does not require the time native collagen does to be utilized by the body and plays a role in every stage of the wound healing process
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
However, if you would like to share the information in this article, you may use the link below:
wound-care.medicaltechoutlook.com/vendor/hymed-facilitating-effective-wound-care-cid-455-mid-45.html